Biological and clinical activity of low dose subcutaneous administration of rIL2 combined with rIFNα2a in advanced malignant melanoma (MM): 297 G. Comelia, G. Castello,A. Daponte,P. Comella,T. Manzo,R. Casaretti, M. NapolitanoMelanoma Research（1993）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
